Drug waste minimisation and cost-containment in Medical Oncology: Two-year results of a feasibility study

Table 2 2006, first semester results

Drug	Total drug prescribing (mg)	Total drug consuming (mg)	Waste proportion (%)	Negotiated^a drug unit pricing (€/mg)	Cost of consumed drugs (€)	Drug waste cost (€)
Bleomycin	0	0	0	1.19	0	0
Carboplatin	62975	63185	0.3	0.082	5181	17
Cetuximab	47940	49300	2.8	2.079	102495	2827
Cyclophosphamide	334314	356500	6.2	0.005	1782	111
Cisplatin	40664	42190	3.6	0.172	7257	262
Dacarbazine	42730	45700	6.5	0.023	1051	68
Docetaxel	15630	16500	5.3	7.525	124162	6547
Doxorubicin	11532	11880	3	1.46	17345	508
Liposomial Doxorubicin.	960	1090	12	17.69	19282	2300
Epirubicin	31350	31580	0.7	1.907	60223	439
Etoposide	11855	14200	16.5	0.022	312	52
5-fluorouracil	2769077	3019370	8.3	0.002	6039	501
Fotemustine	1000	1040	3.8	2.15	2236	86
Gemcitabine	786330	802000	2	0.142	113884	2225
Iphosphamide	132050	137000	3.6	0.014	1918	69
Irinotecan	47995	48695	1.4	1.76	85703	1232
Methotrexate	9118	9700	6	0.055	533	32
Mitomycin	196.5	250	21.4	2.06	515	110
Mitoxantrone	15	20	25	5.39	108	27
Oxaliplatin	47033	49000	4	3.71	181790	7298
Paclitaxel	43932	43932	0	2.376	104382	0
Pemetrexed	26020	30000	13.3	2.54	76200	10109
Raltitrexed	37	42	11.9	62.5	2625	312
Topotecan	114	168	32.2	64.72	10873	3495
Trastuzumab	38433	41328	7	4.69	193828	13577
Vinblastine	25	20	25	0.991	20	5
Vincristine	20	22	9	2.09	46	4
Vindesine	50.5	65	22.3	20.78	1351	301
Vinorelbine	6718	6785	0.9	1.96	13299	131
TOTAL	4508114	4821562	6.5		1134440	52645

ISSN: 1472-6963